HCM
GWPH

Hayman Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Hayman Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-210,715
Closed -$19.3M – 12
2015
Q3 		$19.3M Buy
+210,715
New +$23.4M 8.89% 5

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Hayman Capital Management's GWPH Position: Q4 2015 in Review

Hayman Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2015, closing a stake of 210,715 shares — an estimated $19.3M sold.

Hayman Capital Management first reported a position in GWPH in Q3 2015 and held it in 1 quarter. The position peaked at $19.3M in Q3 2015. 105 funds tracked by Wall St. Rank hold GWPH as of Q4 2015.

  • Hayman Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2015 after selling out during the quarter.
  • Hayman Capital Management sold 210,715 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2015, an estimated $19.3M.
  • Hayman Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 1 quarter.
  • Hayman Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $19.3M in Q3 2015.
  • 105 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2015.

Based on Hayman Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.